EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 348 (2026) EPJ Web Conf., 348 (2026) 01010 References
Open Access
Issue
EPJ Web Conf.
Volume 348, 2026
3rd International Conference on Innovations in Molecular Structure & Instrumental Approaches (ICMSI 2026)
Article Number 01010
Number of page(s) 17
Section Life Science
DOI https://doi.org/10.1051/epjconf/202634801010
Published online 21 January 2026
  1. Goekoop-Ruiterman, Y. P., de Vries-Bouwstra, J. K., Allaart, C. F., et al. (2007). Comparison of treatment strategies in early rheumatoid arthritis: A randomized trial. Annals of Internal Medicine, 146(6), 406-415. https://doi.org/10.7326/0003-4819-146-6-200703200-00003 [Google Scholar]
  2. Hung, C. H., Lu, L. Y, & Huo, A. P. (2024). Rheumatoid arthritis and chronic obstructive pulmonary disease: Pathogenesis and treatment challenges. International Journal of Rheumatic Diseases. [Google Scholar]
  3. Takanashi, S., & Kaneko, Y. (2024). Unmet needs and current challenges of rheumatoid arthritis: Difficult-to-treat rheumatoid arthritis and late-onset rheumatoid arthritis. Journal of Clinical Medicine. [Google Scholar]
  4. Li, Y., Gu, H., & Ma, J. (2024). The research progress of biologics in elderly-onset rheumatoid arthritis (EORA). Frontiers in Aging. [Google Scholar]
  5. Ouyang, Z. M., Zou, Y. W., & Pan, J. (2024). Different prevalence and spectrum of malignancy between Chinese patients and American patients with rheumatoid arthritis. PeerJ. [Google Scholar]
  6. Turesson, C., O'Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2003). Extra-articular disease manifestations in rheumatoid arthritis: Incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases, 62(8), 722–727. https://doi.org/10.1136/ard.62.8.722 [Google Scholar]
  7. Aliagkousi, E., Gavriilaki, E., Doumas, M., Petidis, K., et al. (2012). Cardiovascular risk in rheumatoid arthritis: Pathogenesis, diagnosis, and management. Journal of Clinical Rheumatology, 18, 422–430. https://doi.org/10.1097/RHU.0b013e3182688a64 [Google Scholar]
  8. Dickens, C., McGowan, L., Clark-Carter, D., Creed, F., et al. (2002). Depression in rheumatoid arthritis: A systematic review of the literature with meta-analysis. Psychosomatic Medicine, 64(1), 52–60. https://doi.org/10.1097/01.PSY.0000114683.24978.87 [Google Scholar]
  9. Centers for Disease Control and Prevention. (n.d.). Rheumatoid arthritis. Retrieved from https : //www.cdc. gov/arthritis/basics/rheumatoid. htm [Google Scholar]
  10. Jung, S. M., Kim, K. W., Yang, C. W., Park, S. H., et al. (2014). Cytokine-mediated bone destruction in rheumatoid arthritis. Journal of Immunological Research, 2014, 263625. https://doi.org/10.1155/2014/263625 [Google Scholar]
  11. Margaretten, M., Julian, L., Katz, P., & Yelin, E. (2011). Depression in patients with rheumatoid arthritis: Description, causes, and mechanisms. International Journal of Clinical Rheumatology, 6(6), 617. https://doi.org/10.2217/IIR.1L59 [Google Scholar]
  12. Atzeni, F., Masala, I. F., Di Franco, M., & Sarzi-Puttini, P. (2017). Infections in rheumatoid arthritis. Current Opinion in Rheumatology, 29(4), 323–330. https://doi.org/10.1097/BOR.0000000000000377 [Google Scholar]
  13. Legstrup, B. B., Ellingsen, T., Pedersen, A. B., Darvalics, B., Botker, H. E., & Mœng, M. (2019). P4433 equal cardiovascular risk in patients with diabetes mellitus versus rheumatoid arthritis? European Heart Journal, 40(Supplement_1), ehz745-0835. https://doi.org/10.1093/eurhearti/ehz745 [Google Scholar]
  14. Bathon, J., & Tehlirian, C. (2008). Rheumatoid arthritis clinical and laboratory manifestations. In J. H. Klippel, J. H. Stone, L. J. Crofford, et al. (Eds.), Primer on the Rheumatic Diseases (13th ed., pp. 114–121). Springer. [Google Scholar]
  15. Scott, D. L., Wolfe, F., & Huizinga, T. W. (2010). Rheumatoid arthritis. The Lancet, 376(9746), 1094–1108. https://doi.org/10.1016/S0140-6736(10)60826-4 [Google Scholar]
  16. Ma, Y., Hong, F. F., & Yang, S. L. (2021). Role of prostaglandins in rheumatoid arthritis. Clinical and Experimental Rheumatology, 39(1), 162–725. [Google Scholar]
  17. Sakamoto, C., & Soen, S. (2010). Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan. Digestion, 83(1-2), 108–123. https://doi.org/10.1159/000267898 [Google Scholar]
  18. Goldenberg, M. M. (1999). Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Clinical Therapeutics, 21(9), 1497–1513. https://doi.org/10.1016/S0149-2918(99)80088-0 [Google Scholar]
  19. Olsen, N. J., & Stein, C. M. (2004). New drugs for rheumatoid arthritis. The New England Journal of Medicine, 350, 2167–2179. https://doi.org/10.1056/NE.IMra031588 [Google Scholar]
  20. Siddiqui, H. H. (1993). Safety of herbal drugs—An overview. Drugs News & Views, 1, 7–10. [Google Scholar]
  21. Stuffness, M., & Douros, J. (1982). Current status of the NCI plant and animal product program. Natural Products, 45, 1–14. [Google Scholar]
  22. World Health Organization. (2002). WHO traditional medicine strategy 2002-2005. World Health Organization. [Google Scholar]
  23. Payyappalli, U. (2010). Role of traditional medicine in primary healthcare: An overview of perspectives and challenges. Yokohama Journal of Science, 14, 57–77. [Google Scholar]
  24. Surh, Y. J. (2002). Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food and Chemical Toxicology, 40, 1091–1097. https://doi.org/10.1016/S0278-6915(02)00011-1 [Google Scholar]
  25. Dubey, A., Arora, S., Sharma, S., Kaur, G., Goel, V., Ghildiyal, M., & Kumari, M. (2024). A systemic education of therapeutic approaches using native herbs to treat rheumatoid joint dysfunction. Educational Administration: Theory and Practice, 30(5), 67–83. [Google Scholar]
  26. Saleem, S., Khan, R., Kazmi, I., & Afzal, M. (2019). Medicinal plants in the treatment of arthritis. In M. Ozturk & K. Hakeem (Eds.), Plant and human health, Volume 3. [Google Scholar]
  27. Asad, M., Prasad, K., Thomas, L., & Kamath, J. V. (2007). Evaluation of analgesics and antiinflammatory activity of Sudard, a polyherbal formulation. Iranian Journal of Pharmacology and Therapeutics, 6, 71–75. [Google Scholar]
  28. Shen, X., Li, C., Zhao, H., Li, S., Chen, J., Kobayashi, Y., et al. (2011). Inhibitory effects of a traditional Chinese herbal formula TBL-II on type II collagen-induced arthritis in mice. Journal of Ethnopharmacology, 134, 399–405. https://doi.org/10.1016/j.jep.2010.12.011 [Google Scholar]
  29. Boratyhski, P. J., Zielihska-Blajet, M., & Skarzewski, J. (2019). Cinchona alkaloids—Derivatives and applications. Alkaloids: Chemistry and Biology, 82, 29–145. [Google Scholar]
  30. Liu, C., Yang, S., Wang, K., Bao, X., Liu, Y., Zhou, S., et al. (2019). Alkaloids from traditional Chinese medicine against hepatocellular carcinoma. Biomedicine and Pharmacotherapy, 120, 109543. https://doi.org/10.1016/j.biopha.2019.109543 [Google Scholar]
  31. Roberts, M. F., Strack, D., & Wink, M. (2018). Biosynthesis of alkaloids and betalains. Annual Plant Reviews Online, 20, 91–143. [Google Scholar]
  32. Knolker, H. J. (2017). The alkaloids (Vol. 82). Academic Press. [Google Scholar]
  33. Gomes, J. P., Watad, A., & Shoenfeld, Y. (2018). Nicotine and autoimmunity: The lotus' flower in tobacco. Pharmacological Research, 128, 101–109. https://doi.org/10.1016/j.phrs.2017.12.001 [Google Scholar]
  34. Habtemariam, S. (2020). Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacological Research, 104722. https://doi.org/10.1016/iphrs.2020.104722 [Google Scholar]
  35. Rasouli, H., et al. (2020). Anti-diabetic potential of plant alkaloids: Revisiting current findings and future perspectives. Pharmacological Research, 104723. https://doi.org/10.1016/j.phrs.2020.104723 [Google Scholar]
  36. Wang, X., He, X., Zhang, C. F., Guo, C. R., Wang, C. Z., & Yuan, C. S. (2017). Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthritis in rats. Biomedicine and Pharmacotherapy, 89, 887–893. https://doi.org/10.1016/j.biopha.2017.02.041 [Google Scholar]
  37. Bravo, L. (1998). Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutrition Reviews, 56, 317–333. https://doi.org/10.1111/U753-4887.1998.tb01656.x [Google Scholar]
  38. Ginter, E., Simko, V., & Panakova, V. (2014). Antioxidants in health and disease. Bratislavske Lekarske Listy, 115(10), 603–606. https://doi.org/10.4149/BLL2014 110 [Google Scholar]
  39. Jalili, M., Kolahi, S., Aref-Hosseini, S. R., Mamegani, M. E., & Hekmatdoost, A. (2014). Beneficial role of antioxidants on clinical outcomes and erythrocyte antioxidant parameters in rheumatoid arthritis patients. International Journal of Preventive Medicine, 5(7), 835–840. [Google Scholar]
  40. Khanna, D., Sethi, G., Ahn, K., Pandey, M., Kunnumakkara, A., Sung, B., Aggarwal, A., & Aggarwal, B. (2007). Natural products as a gold mine for arthritis treatment. Current Opinion in Pharmacology, 7(3), 344–351. https://doi.org/10.1016/i.coph.2007.02.005 [Google Scholar]
  41. Rosenbaum, C. C., O'Mathüna, D. P., Chavez, M., & Shields, K. (2010). Antioxidants and anti-inflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Alternative Therapies in Health and Medicine, 16(2), 32–40. [Google Scholar]
  42. Marino, A., Paterniti, I., Cordaro, M., Morabito, R., Campolo, M., Navarra, M., Esposito, E., & Cuzzocrea, S. (2015). Role of natural antioxidants and potential use of bergamot in treating rheumatoid arthritis. PharmaNutrition, 3(2), 53–59. https://doi.org/10.1016/j.phanu.2015.03.002 [Google Scholar]
  43. Newman, D. J., & Cragg, G. M. (2007). Natural products as sources of new drugs over the last 25 years. Journal of Natural Products, 70(3), 461–477. https://doi.org/10.1021/np068053v [Google Scholar]
  44. Garcia-Lafuente, A., Guillamön, E., Villares, A., Rostagno, M. A., & Martinez, J. A. (2009). Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflammation Research, 58(9), 537–552. https://doi.org/10.1007/s00011-009-0041-1 [Google Scholar]
  45. de Villiers, A., Venter, P., & Pasch, H. (2015). Recent advances and trends in the liquid-chromatography-mass spectrometry analysis of flavonoids. Journal of Chromatography A, 1430, 16–78. https://doi.org/10.1016/j.chroma.2015.0L063 [Google Scholar]
  46. Saija, A., Scalese, M., Lanza, M., Marzullo, D., Bonina, F., & Castelli, F. (1995). Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radical Biology and Medicine, 19, 481–486. https://doi.org/10.1016/0891-5849(95)02159-2 [Google Scholar]
  47. Burda, S., & Oleszek, W. (2001). Antioxidant and antiradical activities of flavonoids. Journal of Agricultural and Food Chemistry, 49, 2774–2779. https://doi.org/10.1021/if001577m [Google Scholar]
  48. Peterson, J., & Dwyer, J. (1998). Flavonoids: Dietary occurrence and biochemical activity. Nutrition Research, 18, 1995–2018. https://doi.org/10.1016/S0271-5317(98)00083-7 [Google Scholar]
  49. Jackson, J. K., Higo, T., Hunter, W. L., & Burt, H. M. (2006). The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflammation Research, 55, 168–175. https://doi.org/10.1007/s00011-005-0069-9 [Google Scholar]
  50. Cao, G., Sofic, E., & Prior, R. L. (1997). Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships. Free Radical Biology and Medicine, 22, 749–760. https://doi.org/10.1016/S0891-5849(97)00004-1 [Google Scholar]
  51. Burda, S., & Oleszek, W. (2001). Antioxidant and antiradical activities of flavonoids. Journal of Agricultural and Food Chemistry, 49(6), 2774–2779. https://doi.org/10.1021/if010523i [Google Scholar]
  52. Saija, A., Scalese, M., Lanza, M., Marzullo, D., Bonina, F., & Castelli, F. (1995). Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radical Biology and Medicine, 19(5), 481–486. https://doi.org/10.1016/0891-5849(95)02123-0 [Google Scholar]
  53. Torel, J., Cillard, J., & Cillard, P. (1986). Antioxidant activity of flavonoids and reactivity with peroxy radical. Phytochemistry, 25(2), 383–385. https://doi.org/10.1016/S0031-9422(00)82308-7 [Google Scholar]
  54. Li, A. N., Li, S., Zhang, Y. J., Xu, X. R., Chen, Y. M., & Li, H. B. (2014). Resources and biological activities of natural polyphenols. Nutrients, 6(12), 6020–6047. https://doi.org/10.3390/nu6126020 [CrossRef] [PubMed] [Google Scholar]
  55. Serafini, M., Peluso, I., & Raguzzini, A. (2010). Flavonoids as anti-inflammatory agents. Proceedings of the Nutrition Society, 69(3), 273–278. https://doi.org/10.1017/S0029665110000477 [Google Scholar]
  56. Strugala, P., Tronina, T., Huszcza, E., & Gabrielska, J. (2017). Bioactivity in vitro of quercetin glycoside obtained in Beauveria bassiana culture and its interaction with liposome membranes. Molecules, 22(9), 1520. https://doi.org/10.3390/molecules22091520 [Google Scholar]
  57. Shivappagowdar, A., Pati, S., Narayana, C., Ayana, R., Kaushik, H., Sah, R., Garg, S., Khanna, A., Kumari, J., Garg, L., et al. (2019). A small bioactive glycoside inhibits epsilon toxin and prevents cell death. Disease Models & Mechanisms, 12(1), 1–15. https://doi.org/10.1242/dmm.035143 [Google Scholar]
  58. Yang, P. F., Yang, Y. N., He, C. Y., Chen, Z. F., Yuan, Q. S., Zhao, S. C., Fu, Y. F., Zhang, P. C., & Mao, D. B. (2019). New caffeoylquinic acid derivatives and flavanone glycoside from the flowers of Chrysanthemum morifolium and their bioactivities. Molecules, 24(5), 850. https://doi.org/10.3390/molecules24050850 [Google Scholar]
  59. Ferrer, A., et al. (2017). Emerging roles for conjugated sterols in plants. Progress in Lipid Research, 67, 27–37. https://doi.org/10.1016/jplipres.2017.04.001 [Google Scholar]
  60. Patra, J. K., Shukla, A. C., & Das, G. (Eds.). (2020). Advances in pharmaceutical biotechnology: Recent progress and future applications. Springer Singapore. [Google Scholar]
  61. Ripa, L., Edman, K., Dearman, M., Edenro, G., Hendrickx, R., Ullah, V., & Drmota, T. (2018). Discovery of a novel oral glucocorticoid receptor modulator (AZD9567) with improved side effect profile. Journal of Medicinal Chemistry, 61(5), 1785–1799. https://doi.org/10.1021/acs.jmedchem.7b01473 [Google Scholar]
  62. Yuan, L., Zhang, F., Shen, M., Jia, S., & Xie, J. (2019). Phytosterols suppress phagocytosis and inhibit inflammatory mediators via ERK pathway on LPS-triggered inflammatory responses in RAW264.7 macrophages and the correlation with their structure. Foods, 8(11), 582. https://doi.org/10.3390/foods8110582 [Google Scholar]
  63. Chung, K. T., et al. (1998). Tannins and human health: A review. Critical Reviews in Food Science and Nutrition, 38(6), 421–464. https://doi.org/10.1080/10408699891274193 [Google Scholar]
  64. Lee, D. Y., Kim, H. W., Yang, H., & Sung, S. H. (2017). Hydrolysable tannins from the fruits of Terminalia chebula Retz and their a-glucosidase inhibitory activities. Phytochemistry, 137, 109–116. https://doi.org/10.1016/i.phytochem.2017.03.006 [Google Scholar]
  65. Pellati, F., Bruni, R., Righi, D., Grandini, A., Tognolini, M., Prencipe, F. P., Poli, F., Benvenuti, S., Rio, D. D., & Rossi, D. (2013). Metabolite profiling of polyphenols in a Terminalia chebula Retzius Ayurvedic decoction and evaluation of its chemopreventive activity. Journal of Ethnopharmacology, 147(2), 277–285. https://doi.org/10.1016/ijep.2013.02.013 [Google Scholar]
  66. Juang, L. J., Sheu, S. J., & Lin, T. C. (2004). Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. Journal of Separation Science, 27(9), 718–724. https://doi.org/10.1002/jssc.200400024 [Google Scholar]
  67. Ekambaram, S. P., Perumal, S. S., Erusappan, T., & Srinivasan, A. (2020). Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice. Inflammopharmacology, 28(2), 275–287. https://doi.org/10.1007/s10787-020-00728-5 [Google Scholar]
  68. Seifu, D., Assefa, F., & Abay, S. M. (2012). Medicinal plants as antioxidant agents: Understanding their mechanism of action and therapeutic efficacy. Research Signpost, 97–145. [Google Scholar]
  69. Mousa-Al-Reza Hadjzadeh, Z. R., et al. (2017). Rheum turkestanicum rhizomes possess anti-hypertriglyceridemic, but not hypoglycemic or hepatoprotective effects in experimental diabetes. Avicenna Journal of Phytomedicine, 7(1), 1–7. [Google Scholar]
  70. Kjaerulf, L., et al. (2020). Isolation, structure elucidation, and PTP1B inhibitory activity of serrulatane diterpenoids from the roots of Myoporum insulare. Phytochemistry Letters, 39, 49–56. https://doi.org/10.1016/j.phytol.2020.06.005 [Google Scholar]
  71. Rufino, A. T., Ribeiro, M., Sousa, C., Judas, F., Salgueiro, L., Cavaleiro, C., Mendes, A. F. (2015). Evaluation of the anti-inflammatory, anti-catabolic, and pro-anabolic effects of Ecaryophyllene, myrcene, and limonene in a cell model of osteoarthritis. European Journal of Pharmacology, 750, 141–150. https://doi.org/10.1016/j.ejphar.2015.04.015 [Google Scholar]
  72. Del Prado-Audelo, M. L., Cortés, H., Caballero-Florán, I. H., González-Torres, M., Escutia-Guadarrama, L., Bernal-Chávez, S. A., et al. (2021). Therapeutic applications of terpenes on inflammatory diseases. Frontiers in Pharmacology, 12, 704197. https://doi.org/10.3389/fphar.2021.704197 [Google Scholar]
  73. Ge, J., Liu, Z., Zhong, Z., Wang, L., Zhuo, X., Li, J., et al. (2022). Natural terpenoids with anti-inflammatory activities: Potential leads for anti-inflammatory drug discovery. Bioorganic Chemistry, 124, 105817. https://doi.org/10.1016/ibioorg.2022.105817 [Google Scholar]
  74. Faustino, C., Pinheiro, L., & Duarte, N. (2023). Triterpenes as potential drug candidates for rheumatoid arthritis treatment. Life, 13(7), 1514. https://doi.org/10.3390/life13071514 [Google Scholar]
  75. Bakkali, F., Averbeck, S., Averbeck, D., & Idaomar, M. (2008). Biological effects of essential oils: A review. Food and Chemical Toxicology, 46(2), 446–475. [CrossRef] [PubMed] [Google Scholar]
  76. De, A. K. (2004). The genus Foeniculum. In M. M. Jordral (Ed.), Illicium, Pimpinella, and Foeniculum (pp. 248). CRC Press. [Google Scholar]
  77. Edris, A. E. (2007). Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: A review. Phytotherapy Research, 21(4), 308–323. [Google Scholar]
  78. Saviuc, C. M., Drumea, V., Olariu, L., Chifiriuc, M. C., Bezirtzoglou, E., & Lazär, V. (2015). Essential oils with microbicidal and antibiofilm activity. Current Pharmaceutical Biotechnology, 16(2), 137–151. [Google Scholar]
  79. Sharifi-Rad, J., Sureda, A., Tenore, G. C., Daglia, M., Sharifi-Rad, M., Valussi, M., et al. (2017). Biological activities of essential oils: From plant chemoecology to traditional healing systems. Molecules, 22(1), 70. [Google Scholar]
  80. Pourmortazavi, S. M., & Hajimirsadeghi, S. S. (2007). Supercritical fluid extraction in plant essential and volatile oil analysis. Journal of Chromatography A, 1163, 2–24. [Google Scholar]
  81. Yang, S. C., & Hwang, T. L. (2016). The potential impacts of formyl peptide receptor 1 in inflammatory diseases. Frontiers in Bioscience (Elite Ed.), 8, 436–449. [Google Scholar]
  82. Bhuwane, N., Mishra, R., Nagdev, S., Alok, S., Golani, P., Lodhi, D. S., & Mude, G. (2022). Comprehensive study of Vanda roxburghii: Traditional uses, phytochemistry, and pharmacological significance. International Journal of Pharmaceutical Sciences and Research, 13(12), 4901–4908. [Google Scholar]
  83. Jain, A., Choubey, S., Singour, P. K., Rajak, H., & Pawar, R. S. (2011). Sida cordifolia (Linn) - An overview. Journal of Applied Pharmaceutical Science, 1(2), 23–31. [Google Scholar]
  84. Ribeiro, P. R., de Castro, R. D., & Fernandez, L. G. (2016). Chemical constituents of the oilseed crop Ricinus communis and their pharmacological activities: A review. Industrial Crops and Products, 91, 358–376. [Google Scholar]
  85. Ganjewala, D., & Srivastava, A. K. (2011). An update on chemical composition and bioactivities of Acorus species. Asian Journal of Plant Sciences, 10(3), 182–189. [Google Scholar]
  86. Al-Nahain, A., Jahan, R., & Rahmatullah, M. (2014). Zingiber officinale: A potential plant against rheumatoid arthritis. Hindawi Publishing Corporation, Arthritis, Article ID 159089, 8 pages. [Google Scholar]
  87. Telang-Chaudhari, S., Singh, J., Chaudhari, H., Aher, V., Pande, S., & Pande, S. (2024). Vitex negundo Linn (Nirgundi): Journey from past to future therapeutic prospects. International Journal of Pharmaceutical and Clinical Research, 16(2), 797–804. [Google Scholar]
  88. Gautam, R. K., Roy, K., Thapa, G., Arora, D., Parashar, S., Gurung, B., & Deb, L. (2020). Perspective of plant medicine in therapy of rheumatoid arthritis. Indian Journal of Pharmaceutical Sciences, 82(5), 741–765. [Google Scholar]
  89. Sharma, A., Singh, N., & Bharadwaj, R. (2016). Ethno-pharmaco-therapeutic activities of Cyperus rotundus. International Journal of Multidisciplinary Approach and Studies, 3(2), 33–38. [Google Scholar]
  90. Sannegowda, K. M., Venkatesha, S. H., & Moudgil, K. D. (2015). Tinospora cordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage. International Journal of Immunopathology and Pharmacology, 28(4), 521–531. [Google Scholar]
  91. Choudhary, S., Kaurav, H., Chaudhary, G. (2021). Gokhru (Tribulus terrestris and Pedalium murex): Medicinal importance of Chota Gokhru and Bada Gokhru in Ayurveda and modern science. Asian Journal of Pharmaceutical Clinical Research, 14(6), 6–13. [Google Scholar]
  92. Mandlik, D. S., & Namdeo, A. G. (2020). Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects. Journal of Dietary Supplements. [Google Scholar]
  93. Yadav, V., Krishnan, A., & Vohora, D. (2019). A systematic review on Piper longum L.: Bridging traditional knowledge and pharmacological evidence for future translational research. Journal of Ethnopharmacology. [Google Scholar]
  94. Variya, B. C., Bakrania, A. K., & Patel, S. S. (2016). Emblica officinalis (Amla): A review for its phytochemistry, ethnomedicinal uses, and medicinal potentials with respect to molecular mechanisms. Pharmacological Research, 111, 180–200. [Google Scholar]
  95. Parmar, D., Jain, N. K., & Tomar, V (2018). Anti-arthritic evaluation of different extracts of Boerhaavia diffusa Linn. in FCA-induced arthritis in rats. Journal of Drug Delivery and Therapeutics, 8(5-s), 388–393. [Google Scholar]
  96. Kohli, K., Ali, J., Ansari, M. J., & Raheman, Z. (2005). Curcumin: A natural anti-inflammatory agent. Indian Journal of Pharmacology, 37(3), 141–147. [Google Scholar]
  97. Neogi, N. C., Rathor, R. S., Shrestha, A. D., & Banerjee, D. K. (1969). Studies on the anti-inflammatory and anti-arthritic activity of Achyranthine. Indian Journal of Pharmacology, 1, 37–47. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.